companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

SHANDONG RUSHAN ART & CRAFT PRODUCT GROUP CO LTD

-China

Company Name:
Corporate Name:
SHANDONG RUSHAN ART & CRAFT PRODUCT GROUP CO LTD
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 46 Shengli Street, Rushan City, Shandong,,,China 
ZIP Code:
Postal Code:
264500 
Telephone Number: 86-896-6622421 
Fax Number:  
Website:
 
Email:
 
Industrial Classification: Household products -- Toys -- Stuffed toys, downy toys 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
JIANGSU JEWEL & CHEMICAL FIBRE GROUP CO.LTD.
YIZHENG CITY CHENJIXIANG SHUANGFU TOYS FTY
JIANGDU CITY ART & CRAFTS TOYS FTY
Next company profile:
NINGBO CITY ART & CRAFTS TOYS CO LTD SHENGZHOU CITY COOPERATIVE FACTORY
FENGSHENG ART & CRAFT PRODUCT CO LTD
JOINT-VENTURE WUXI JILI ART & CRAFT PRODUCT CO LTD










Company News:
  • Evolving Trends in Catheter-Directed Therapy for Venous Thrombosis: A . . .
    The authors write this letter to draw attention to the changing trends of utilization of catheter-directed thrombolytic therapy (CDT) for the treatment of venous thrombosis in the Medicare population from 2013 to 2022 These trends have been reported previously by Von Ende et al (1) from 2007 to 2017, utilizing the Centers for Medicare Medicaid Services (CMS) 5% research identifiable files
  • Catheter-Directed Therapies for Deep Vein Thrombosis and Pulmonary . . .
    Background Nationwide trends in the utilization of catheter-directed therapies for deep vein thrombosis and pulmonary embolism in the Medicare population are essential as they represent a major health care challenge The annual incidence and mortality with venous thromboembolism are around 900,000 and 60,000 to 100,000 patients, respectively, in the United States Methods Data were acquired
  • Trends in Advanced Treatment Utilization After Adoption of Large-bore . . .
    We assessed changes in trends in utilization of advanced treatments (systemic thrombolysis, catheter-directed thrombolysis, and large-bore embolectomy) and hospital practices following the adoption of large-bore embolectomy for patients with intermediate- and high-risk pulmonary embolism
  • Nationwide Trends in Use of Catheter-Directed Therapy for Treatment of . . .
    Methods Using a 5% national sample of Medicare claims data from 2004 to 2016, all claims associated with PE were identified The annual volume of 2 billable CDT services—arterial mechanical thrombectomy and transcatheter arterial infusion for thrombolysis—were determined to evaluate changes in CDT use and primary CDT operator specialty over
  • Utilization trends and outcomes of catheter-directed thrombolysis for . . .
    Contemporary data on catheter-directed thrombolysis (CDT) utilization trends and associated hospital outcomes in pulmonary embolism (PE) n the US is limited Using the nationwide inpatient sample database, we identified patients hospitalized for acute PE treated with CDT from January 1, 2008, to December 31, 2018 Cochrane-Armitage test was used to evaluate the temporal trends in utilization
  • Nationwide Trends in Catheter-Directed Therapy Utilization for the . . .
    To determine overall and provider specialty trends in the use of catheter-directed therapy for lower extremity deep vein thrombosis (DVT) treatment in the Medicare population
  • Catheter directed thrombolysis for deep vein thrombosis in 2022 . . .
    The utilization of Catheter directed thrombolysis (CDT) as a treatment modality for patients with proximal and caval deep vein thrombosis (DVT) has increased over time despite conflicting evidence (Fig 1) [1, 2]
  • Trends in Percutaneous Device Use for the Treatment of Venous . . .
    In the PHD cohort, specific reperfusion devices were identified in 14,105 patients (PE 9,098, iDVT 5,007) In conclusion, the use of mechanical thrombectomy for the treatment of VTE has increased over time, whereas the rates of catheter-directed thrombolysis therapy have remained stagnant or decreased
  • Comparative Outcomes of Catheter-Directed Thrombolysis Plus . . .
    Bashir and colleagues compare in-hospital outcomes in the treatment of acute proximal deep vein thrombosis using anticoagulation plus catheter-directed thrombolysis (CDT) vs anticoagulation alone They also evaluate the temporal trends in CDT utilization and outcomes in proximal DVT treatment
  • Nationwide Trends of Catheter-Directed Therapy Utilization for . . .
    The annual volume of two services – venous percutaneous transluminal thrombectomy (CPT code 37187) and venous infusion for thrombolysis (CPT code 37201 from 2007-2012 and CPT code 37212 from 2013-2017) – were examined for trends in DVT intervention Utilization rates as well as region and place of service were calculated




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer